Reg. no. 5594104522 · Other research and experimental development on natural sciences and engineering · SOLNA
Idorsia Pharmaceuticals Nordics AB is registered with the legal form Limited company, is based in SOLNA and is active in Other research and experimental development on natural sciences and engineering. Revenue for 2025 was 31.8 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
31.8 MSEK
▲ +43%Operating result
140 kSEK
▼ −81%Net result
130 kSEK
▼ −80%Employees (annual report)
5
▲ +25%Total assets
15 MSEK
Equity
7.1 MSEK
Equity ratio
47.3 %
Profit margin
0.4 %
MSEK
Idorsia Pharmaceuticals Nordics AB increased net sales by 43.2 % to 31.8 MSEK in 2025. Each of the three most recent comparable fiscal periods (2023–2025) ended in profit. In 2025, net sales corresponded to roughly 6.4 MSEK per employee (5 employees).
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Idorsia Pharmaceuticals Nordics AB's reg. no. is 5594104522.
Idorsia Pharmaceuticals Nordics AB reported revenue of 31.8 MSEK for the fiscal year 2025.
Yes — Idorsia Pharmaceuticals Nordics AB reported a net profit of 0.1 MSEK for 2025.
Idorsia Pharmaceuticals Nordics AB had 5 employees as of the most recently reported period (2025).
Idorsia Pharmaceuticals Nordics AB is registered under Other research and experimental development on natural sciences and engineering.
Idorsia Pharmaceuticals Nordics AB is based in SOLNA.
arkivnord